-+ 0.00%
-+ 0.00%
-+ 0.00%

Plus Therapeutics names Randy Goodman vice president of value strategy, HEOR

PUBT·04/15/2026 11:31:44
Listen to the news
Plus Therapeutics names Randy Goodman vice president of value strategy, HEOR
  • Plus Therapeutics appointed Randy H. Goodman as vice president, value strategy and health economics and outcomes research, effective April 13, 2026.
  • Goodman brings more than 20 years of market access and health economics experience across biotech, pharmaceuticals, diagnostics, and medical devices.
  • He has advised Pfizer, Gilead Sciences, Moderna, and worked with Centers for Medicare & Medicaid Services on value-based pricing and reimbursement frameworks.
  • Role centers on value strategy and market access to support CNSide Diagnostics commercialization and build reimbursement evidence for REYOBIQ and broader CNS oncology pipeline.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604150730PRIMZONEFULLFEED9689822) on April 15, 2026, and is solely responsible for the information contained therein.